ask="3.12"
ask_size="500"
average_daily_volume="4140900"
bid="2.99"
bid_size="1500"
book_value="-1.75"
change="+0.12"
change_from_200_day_moving_average="-2.04"
change_from_50_day_moving_average="-1.18"
change_from_52_week_high="-5.92"
change_From_52_week_low="0.27"
change_in_percent="+4.03%"
close="3.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.12"
high_52_weeks="9.02"
last_trade_date="1/24/2017"
last_trade_price="3.10"
last_trade_size="123222"
last_trade_time="4:00pm"
low="2.89"
low_52_weeks="2.83"
market_capitalization="401.81M"
moving_average_200_day="5.14"
moving_average_50_day="4.28"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="2.98"
pe_ratio="N/A"
peg_ratio="-0.46"
percent_change_from_200_day_moving_average="-39.69%"
percent_change_from_50_day_moving_average="-27.63%"
percent_change_from_52_week_high="-65.61%"
percent_change_from_52_week_low="+9.54%"
previous_close="2.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.70"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="14.12"
stock_exchange="NGM"
symbol="MACK"
volume="2915013"
weeks_range_52="2.83 - 9.02"
